Peritoneal dialysis fluid induces p38-dependent inflammation in human mesothelial cells

Andrea Riesenhuber1, Klaus Kratochwill, Thorsten O Bender

  • 1Department of Pediatrics, Medical University, Vienna, Austria.

Abstract

Insights

The p38 mitogen-activated protein kinase (MAPK) pathway regulates inflammatory and stress responses in mesothelial cells exposed to peritoneal dialysis fluids (PDF). Inhibiting p38 reduces IL-8 and HSP70 upregulation, linking this pathway to cellular stress.

Area of Science:

  • Cellular Biology
  • Renal Physiology
  • Inflammation Research

Background:

  • Peritoneal dialysis fluids (PDF) can induce noninfectious inflammatory responses in mesothelial cells.
  • This inflammatory response is part of the cellular stress reaction to PDF exposure.

Purpose of the Study:

  • To investigate the role of the stress-inducible mitogen-activated protein kinase (MAPK) p38 pathway.
  • To understand how p38 regulates inflammatory and stress responses in mesothelial cells exposed to PDF in vitro.

Main Methods:

  • Human peritoneal mesothelial cells were exposed to two types of PDF (Dianeal PD4, Physioneal).
  • Key markers including p38 phosphorylation, heat shock protein-70 (HSP70), lactate dehydrogenase (LDH), and interleukin (IL)-8 were measured.
  • The effect of a p38 inhibitor (SB203580) on these markers was assessed.

Main Results:

  • Dianeal induced significant p38 phosphorylation, IL-8 release, HSP70 expression, and LDH release.
  • Physioneal showed less pronounced changes in IL-8, HSP70, and LDH.
  • SB203580 treatment dampened IL-8 release and HSP70 expression in Dianeal-exposed cells, while LDH release remained unchanged.

Conclusions:

  • The p38 MAPK pathway is critically involved in the upregulation of IL-8 and HSP70 in mesothelial cells exposed to bioincompatible PDF.
  • This pathway serves as a crucial link between pro-inflammatory processes and the cellular stress response in human peritoneal mesothelial cells.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...